Histological Alterations Induced by Atorvastatin Therapeutic Doses in some Organs of Male Albino Rats
DOI:
https://doi.org/10.25156/ptj.v9n1y2019.pp13-16Keywords:
Atorvastatin, Kidney, Liver, Rats, TestisAbstract
Vascular disease and heart attacks are a common phenomenon in the modern world, where lipid accumulates inside blood vessels and causes plug, eventually heart stroke and death. Utilize lipidlowering drugs are the most effective factors to prevent heart disease. Atorvastatin is the most important drugs that used in this field. The aim of this study was to investigate the adverse effects of atorvastatin (20 mg/kg/b.wt/day) on some organs of albino. 12 adult male albino rats weighing 200 ± 20 g were used and divided into two groups: First group served as control group, was given 0.72 ml distilled water/rat. The second group was subjected to treatments with atorvastatin in a dose of 20 mg/kg/b.wt/day as a single daily dose (0.72 ml contained 1.44 mg of atorvastatin) orally by gastric tube for 4 weeks. Histological alterations were examined, and the results of atorvastatintreated groups showed changes in the kidney sections, which include focal tubular edema and glomerular atrophy, also liver sections revealed foci of lymphocyte accumulation, cytoplasmic vacuolization, as well as sections of the testes showed degenerative changes in the seminiferous tubules. According to this study, we can conclude that atorvastatin-induced various deleterious changes in the histological structure of the testes, kidneys and cause mild liver alteration of adult male albino rat.
Downloads
References
Bancroft, J. D. and M. Gamble. 2008. Theory and Practice of Histological Techniques. 6th ed. Churchill Livingstone, London. p340-348.
Bosch, X. A., E. B. Poch and J. M. Grau. 2009. Rhabdomyolysis and acute kidney injury. N. Engl. J. Med. 361: 62-72.
Brugnon, F. 2014. Evaluation of atorvastatin efficacy and toxicity on spermatozoa, accessory glands and gonadal hormones of healthy men: A pilot prospective clinical trial. Reprod. Biol. Endocrinol. 12(1): 1-12.
Brunton, L. L., B. A. Chabner and B. C. Knollmann. 2011. Goodman and Gilman’s: The Pharmacological Basis of Theraputics. 12th ed. McGraw Hill Medical, New York, Chicago and San Francisco. p877-878.
Goldstein, J. L. and M. S. Brown. 1990. Regulation of the mevalonate pathway. Nature. 343: 425-30.
Hoofnagle, J. H. 2017. Identification and Characterization of Fenofibrate-Induced Liver Injury. Digestive Diseases and Sciences. Springer, US.
Jaikumkao, K., A. Pongchaidecha, N. Chattipakorn, V. Chatsudthipong, S. Promsan, P. Arjinajarn and A. Lungkaphin. 2016. Atorvastatin improves renal organic anion transporter 3 and renal function in gentamicin-induced nephrotoxicity in rats. Exp. Physiol. 101(6): 743-753.
Miller, M. 2009. Commentary dyslipidemia and cardiovascular risk: The importance of early prevention. QJM. 102(9): 657-667.
Mizugushi, Y., A. Miyajima, T. Kosaka, T. Asano and M. Hyakawa. 2004. Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. J. Urol. Dec. 172(6): 2456-2459.
Mostafa, A., A. F. Mohammed and S. M. Hanafi. 2015. Effect of atorvastatin on the testis of adult male albino, Al Azhar Assiut Med. J. 13(4): 100-118.
Paget, G. C. and J. M. Barnes. 1964. Toxicity in Evaluation of the Drug Activities. Pharmacometric ed. Lournace and bacharachai. Academic press, London and New York. p1-13.
Pal, S., M. Ghosh, S. Ghosh, S. Bhattacharyya and P. C. Sil. 2015. Atorvastatin induced hepatic oxidative stress and apoptotic damage via MAPKs, mitochondria, calpain and caspase12 dependent pathways. Food Chem. Toxicol. 83: 36-47.
Pasternak, R. C., S. C. Smith and C. N. BaireyMerz. 2002. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Stroke. 33: 2337-2341.
Pons-Rejraji, H., F. Brugnon, B. Sion, S. Maqdasy, G. Gouby, B. Pereira, G. Marceau, A. Gremeau, J. Drevet, G. Grizard, L. Janny and I. Tauveron. 2014. Evaluation of atorvastatin efficacy and toxicity on spermatozoa, accessory glands and gonadal hormones of healthy men: A pilot prospective clinical trial. Reprod. Biol. Endocrinol. 12: 65-66.
Schmechel, A., M. Grimm, A. H. El Armouche and T. Eschenhagen. 2009. Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects. Cardiovasc. Res. 82(1): 100-106.
Undas, A., K. E. Brummel-Ziedins and K. G. Mann. 2014. Anticoagulant effects of statins and their clinical implications. Thromb. Haemost. 111(3): 392-400.
Vanholder, R., M. S. Sever, E. Erek and N. Lameire. 2000. Rhabdomyolysis. J. Am. Soc. Nephrol. 11(8): 1553-1561.
Wang, Q., Y. Y. Su, Y. Q. Li, Y. F. Zhang, S. Yang, J. L. Wang and H. Y. Li. 2017. Atorvastatin alleviates renal ischemia-reperfusion injury in rats by promoting M1-M2 transition. Mol. Med. Rep. 15(2): 798-804.
Wierzbicki, A. S., J. A. Herd, C. M. Ballantyne and J. A. Farmer. 1999. Thrombotic vascular events after change of statin. Lancet. 353(9155): 845.
Zahr, R. S., P. Chappa, H. Yin, L. A. Brown, K. I. Ataga and D. R. Archer. 2018. Renal protection by atorvastatin in a murine model of sickle cell nephropathy. Br. J. Haematol. 181(1): 111-121.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Twana Mustafa, Hamza Abdulah
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).